ClinicalTrials.gg
Status unknownNCT05750277Updated Apr 24, 2023

The Feasibility of Early Time-Restricted Eating in a Student Population

An interventional study of Evening Time-Restricted Eating in Time Restricted Feeding and Intermittent Fasting, sponsored by Nottingham Trent University. Status unknown at 1 site in United Kingdom. Open to participants aged 18 Years to 30 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2023-04-24.

Sponsored by Nottingham Trent University · Not applicable, Interventional, and Prevention

The sponsor has not verified this record recently (last verified Apr 2023), so the status shown — last known as Active, not recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
16
Allocation
Non-randomized
Ages
18 Years to 30 Years
Sex
All
01

Study summary

This study proposes to investigate the effect of a self-selected early time-restricted eating window in University students.

Read the detailed description

There were over 2.3 million students registered at Higher Education institutes in the UK. Early adulthood is a critical time for establishing self-care habits which will ultimately influence health outcomes later in adulthood and studies suggest that the overall health of students is poor relative to that of their age-matched peers not in education. Therefore, the investigators would like to assess the feasibility of adopting a novel, nutritional intervention in this important, understudied population.

Previous research has shown Early Time-Restricted Eating can reduce daily energy consumed and improve markers of health over time, in a range of populations. Therefore, the investigators are investigating how often participants can eat within an early 8 hour eating window, starting no earlier than 8am (finishing calorie intake by 4pm), or no later than 10am (finishing calorie intake by 6pm). The investigators will be measuring how often the participants can adhere to this eating window between Monday to Friday, with the study lasting 4 weeks in total. This is a feasibility study, so this study will investigate whether this intervention is achievable and what social barriers may exist which reduce adherence to this eating window. Participants will visit the laboratory on 3 occasions (at the start, halfway point, and at the end of the intervention) to measure any changes in health markers across the intervention. The lab visits will involve providing a finger-tip blood sample, and measuring body mass, blood pressure, and waist-to-hip circumference. Outside of the laboratory, participants are required to record their eating window on a mobile app and an investigator-created trial sheet. Further measures outside of the laboratory will include a weekly questionnaire and motivational correspondence via mobile text message.

02

Conditions studied

  • Time Restricted Feeding
  • Intermittent Fasting

Browse trials for

Keywords

  • Students
  • Metabolism
  • Appetite
03

In context

Intermittent Fasting

333 studies on the registry are indexed under Intermittent Fasting; 99 are open to participants now.

This study's enrollment of 16 is below the median of 50 across 320 interventional studies indexed under Intermittent Fasting.

Browse Intermittent Fasting studies →

Lead sponsor

Nottingham Trent University is the lead sponsor of 30 studies on the registry; 5 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 30 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Registered student

Exclusion criteria

Exclusion Criteria:

  • Not taking any medication which is known to affect appetite
05

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Non-randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
16 participants (actual)

Study arms

  • Experimental
    Early Time-Restricted Eating

    This group will self-select their eating window as long as it is between 8am-6pm, and will aim to fast within this window as many occasions as possible between Monday-Friday for 4 weeks.

    Other: Evening Time-Restricted Eating

  • No intervention
    Control

    This group will maintain their habitual lifestyle for 4 weeks.

Interventions

  • OtherEvening Time-Restricted Eating

    Eating between 8am-6pm.

06

What researchers measure

Primary outcomes

  1. Successful bouts of Early Time-Restricted Eating

    Successful Early Time-Restricted Eating occasions will be recorded by the participant on a mobile device and an investigator-created trial sheet.

    Time frame: 4 weeks

Secondary outcomes

  1. Glucose

    How their glucose concentrations change over the trial

    Time frame: 4 weeks

  2. Insulin

    How their Insulin concentrations change over the trial

    Time frame: 4 weeks

  3. HbA1C

    How their HbA1CA concentrations change over the trial

    Time frame: 4 weeks

  4. Body mass

    How their body mass changes over the trial

    Time frame: 4 weeks

  5. Blood pressure

    How blood pressure (systolic and diastolic) changes over the trial

    Time frame: 4 weeks

  6. Body fat percentage

    How their body fat percentage changes over the trial

    Time frame: 4 weeks

  7. Waist to hip ratio

    How their waist to hip ratio changes over the trial

    Time frame: 4 weeks

  8. Appetite

    Investigators will record appetite sensations, such as; hunger, fullness, prospective food consumption, desire to eat and nausea. Investigators will record these validated sensations to observe any changes across the trial. A visual analogue scale (100mm) will be digitised and sent to the participant by mobile text to record changes in the aforementioned appetitte sensations.

    Time frame: 4 weeks

07

Study locations

1 site
  • Nottingham Trent University
    Nottingham, Greater London NG11 8NS, United Kingdom
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 24, 2023, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT05750277
Lead sponsor
Nottingham Trent University
Responsible party
William Mode (Principal Investigator, Nottingham Trent University) — Principal investigator
First posted
Mar 1, 2023
Start date
Apr 19, 2023
Primary completion
May 18, 2023 (estimated)
Completion
May 19, 2023 (estimated)
Last update
Apr 24, 2023

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Apr 2023. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion